VE-303
N/A
Report date: 2025/06/06 20:01:13
Base Information
Drug NameVE-303
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[24]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesVedanta Biosciences Inc
China Registration ClassN/A
Develop Information
Active CompaniesVedanta Biosciences Inc
Inactive CompaniesN/A
Active Indications +[5]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A